Abstract:Rosai-Dorfman disease (RDD) is a rare non-malignant histiocytosis
disorder, commonly manifesting with massive painless cervical
lymphadenopathy. Renal involvement develops in only four percent of
patients with RDD. Generally, RDD is self-limiting and has a good
prognosis; however, in patients with renal involvement, mortality rate
can be as high as 40%.
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.